Accelerated development of vaccine benefit-risk collaboration in Europe
Site Search
Site Search
Displaying results 1 - 10 of 78
Biomarkers for Enhanced Vaccine Immunosafety
Standardization and development of assays for assessment of influenza vaccines correlates of protection
17/05/2022
Vaccine potency drops in the elderly and little is known about why this happens. Now European scientists are on a mission to understand waning immunity and to develop strategies...
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment
Ebola and other filoviral haemorrhagic fevers
Zoonotic anticipation and preparedness initiative
12/04/2022
COVID-19 vaccines do not raise the risk of developing four rare neurological disorders, but an increased risk was seen in unvaccinated infected people with the disease.
Manufacturing and development for rapid access Ebola vaccine
Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance
